Quaker Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Quaker Wealth Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$47.98 - $54.4 $8,252 - $9,356	172 Added 3.75%	4,758 $258,000
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $64,866 - $77,403	-1,338 Reduced 22.59%	4,586 $235,000
Q3 2023 Oct 19, 2023	BUY	$57.89 - $64.73 $110,512 - $123,569	1,909 Added 47.55%	5,924 $343,000
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $70,654 - $78,450	1,109 Added 38.16%	4,015 $256,000
Q1 2023 Apr 25, 2023	SELL	$65.71 - $74.53 $591 - $670	-9 Reduced 0.31%	2,906 $201,000
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $479 - $567	7 Added 0.24%	2,915 $210,000
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $24 - $14,753	-192 Reduced 6.19%	2,908 $207,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $508 - $559	7 Added 0.23%	3,100 $239,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $85,580 - $102,618	-1,392 Reduced 31.04%	3,093 $226,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $240,530 - $280,402	4,485 New	4,485 $280,000
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $144,768 - $210,381	-3,120 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $153,535 - $200,272	3,120 New	3,120 $200,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Quaker Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quaker Wealth Management, LLC with notifications on news.